# Embryo QUAlity in Ovarian Stimulation With hMG.

> **NCT07691073** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Fundacion Dexeus** · enrollment: 240 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** 10 mcg of follitropin-delta + 150 of hMG
- **DRUG:** 5 mcg of follitropin-delta + 225 of hMG

## Key facts

- **NCT ID:** NCT07691073
- **Lead sponsor:** Fundacion Dexeus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-02
- **Final completion:** 2029-05
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691073, "Embryo QUAlity in Ovarian Stimulation With hMG.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07691073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*